drugset / Trial / NCT07226258
Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain
RandomizedSequentialQuadruple-blindTreatment
Summary
A Randomized, Double-Blind, Placebo-Controlled, Single Dose Study to Assess the Safety and Efficacy of SL1002 for the Treatment of Knee Pain in Patients with Osteoarthritis of the Knee.
Timeline
- Start
- 2025-11-07
- Primary completion
- 2026-11-30
- Completion
- 2027-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SL-1002 | Unknown | — | — |